As an auxiliary therapy for gastric cancer, JPBS combined with chemotherapy improved the efficiency of clinical curative effect, increased KPS score, increased the levels of CD3+, CD4+, CD4+/CD8+, NK+, and macrophages, and reduced the level of CD8+ and the rates of decline of WBC, PLT, and Hb. Here, CD8A is linked to gastric cancer.